Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acurx Pharmaceuticals Inc...

    NASDAQ: ACXP · Real-Time Price · USD
    5.11
    0.25 (5.14%)
    At close: Aug 15, 2025, 3:59 PM
    5.12
    0.20%
    After-hours: Aug 15, 2025, 05:58 PM EDT

    Acurx Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 6.06B 4.64M 3.71M 5.76M 6.36M 8.92M 7.47M 7.05M 9.15M 7.18M 9.11M 10.61M 9.09M 11.08M 12.96M 14.46M 17.1M 2.63M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 264.95M n/a 50.25K n/a 295.3M n/a n/a 339.48K
    Receivables
    		 40.21K n/a 51.13K 97.37K 51.13K n/a 129.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 -93.73K -574 -250 -195 n/a 92.00 65.00 278.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Current Assets
    		 6.06B 4.8M 3.86M 5.98M 6.58M 9.11M 7.71M 7.16M 9.24M 7.38M 9.38M 10.95M 9.21M 11.32M 13.25M 14.99M 17.44M 2.64M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 264.95M n/a 50.25K n/a 295.3M n/a n/a 339.48K
    Total Assets
    		 6.16B 4.8M 3.86M 5.98M 6.58M 9.11M 7.71M 7.16M 9.24M 7.38M 9.38M 10.95M 9.26M 11.32M 13.25M 14.99M 17.44M 2.98M
    Account Payables
    		 n/a n/a n/a 19.1K 10.13K 9.2K 3.81K 11.72K 12.88K 18.41K 29.54K 5.94K 5.76K 6.36K 63.37K 12.14K 97K 396.00
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16.63K
    Other Current Liabilities
    		 2.59B 2.49B 2.7M 247.9K 42.31K -202 -438 206.28K n/a 20.39K 542.89K n/a 26.09K n/a n/a n/a n/a n/a
    Total Current Liabilities
    		 2.59B 2.49B 3.24M 3.32M 3.15M 3.11M 3.04M 3.22M 3.02M 2.07M 2.06M 1.18M 473.88K 633.03K 843.91K 712.44K 1.92M 460.8K
    Long-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 49.88K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.06M n/a n/a n/a n/a n/a n/a 49.88K
    Total Liabilities
    		 2.59B 2.49B 3.24M 3.32M 3.15M 3.11M 3.04M 3.22M 3.02M 2.07M 2.06M 1.18M 473.88K 633.03K 843.91K 712.44K 1.92M 510.68K
    Total Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 66.5K
    Common Stock
    		 1.47M 22.4K 17.03K 16.77K 16K 15.76K 14.47K 13.01K 13.01K 11.67K 11.63K 11.59K 10.26K 10.26K 10.22K 10.13K 9.92K 17.75M
    Retained Earnings
    		 -71.72B -69.47M -67.32M -64.54M -61.72M -57.6M -53.22M -48.1M -44.99M -41.54M -38.64M -35.38M -31.84M -29.22M -26.55M -23.92M -19.28M -15.28M
    Comprehensive Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -38.64M -35.38M -31.84M -29.22M -26.55M -23.92M -19.28M -15.28M
    Shareholders Equity
    		 3.57B 2.31M 615.12K 2.66M 3.43M 6M 4.67M 3.94M 6.22M 5.31M 7.32M 9.76M 8.79M 10.69M 12.41M 14.28M 15.52M 2.47M
    Total Investments
    		 n/a n/a n/a 5.76B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist